Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
Capital Expenditures
Pulmonx Corp
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pulmonx Corp
NASDAQ:LUNG
|
Capital Expenditures
-$807k
|
CAGR 3-Years
4%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Capital Expenditures
-$427.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-7%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Capital Expenditures
-$144m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Capital Expenditures
-$177.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-25%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Capital Expenditures
-$119m
|
CAGR 3-Years
-113%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-37%
|
See Also
What is Pulmonx Corp's Capital Expenditures?
Capital Expenditures
-807k
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Capital Expenditures amounts to -807k USD.
What is Pulmonx Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-20%
Over the last year, the Capital Expenditures growth was 39%. The average annual Capital Expenditures growth rates for Pulmonx Corp have been 4% over the past three years , -20% over the past five years .